K. Nomura

Learn More
  • J.L. Landa, Chevron Energy Technology Co, and R.K. Kalia, A. Nakano, K. Nomura, and P. Vashishta +1 other
  • 2005
This paper was selected for presentation by an IPTC Programme Committee following review of information contained in an proposal submitted by the author(s). Contents of the paper, as presented, have not been reviewed by the International Petroleum Technology Conference and are subject to correction by the author(s). The material, as presented, does not(More)
Breast cancer cells are known to express various proteolytic enzymes, which make them invasive and favour their dissemination to distant sites. However, it is unclear whether breast cancer cells have the ability to produce polymorphonuclear leucocyte elastase (PMN-E). We measured immunoreactive (ir) PMN-E content in the conditioned medium of two breast(More)
Plasminogen activator (PA) is a serine protease which exists in two forms: tissue-type (t-PA) and urokinase-type (u-PA). The total PA activity was measured in tumour extracts of 235 breast cancer patients who were followed for a median of 8.5 years after surgery. Patients were initially divided into three groups with low (< 60 units mg-1 protein),(More)
Plasminogen activator (PA) is a serine protease existing in two forms known as tissue-type (t-PA) and urokinase-type (u-PA). To examine whether PA is related to the postoperative clinical course of human breast cancer, total PA activity, t-PA activity, u-PA activity, and immunoreactive t-PA were determined in tissue extracts from 144 breast cancer(More)
In this work, iron-doped SnO 2 powders were prepared by two methods: mechanical alloying and mechanochemical alloying with successive thermal treatment. The influence of different milling conditions such as ball to powder weight ratio, milling time, rotation velocity of supporting disc and the type of iron starting reactive and their Fe concentration on the(More)